Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$191.51 - $216.16 $45.9 Million - $51.9 Million
-239,900 Reduced 26.76%
656,500 $139 Million
Q2 2023

Aug 11, 2023

BUY
$187.64 - $206.25 $86.1 Million - $94.7 Million
459,100 Added 104.99%
896,400 $173 Million
Q1 2023

May 16, 2023

BUY
$127.59 - $203.08 $44.3 Million - $70.5 Million
347,000 Added 384.27%
437,300 $88.5 Million
Q4 2022

Feb 14, 2023

SELL
$117.37 - $139.17 $29.9 Million - $35.5 Million
-255,100 Reduced 73.86%
90,300 $11.6 Million
Q3 2022

Nov 14, 2022

BUY
$135.27 - $180.11 $21.7 Million - $28.9 Million
160,200 Added 86.5%
345,400 $47.3 Million
Q2 2022

Aug 15, 2022

BUY
$108.81 - $179.33 $12.2 Million - $20.1 Million
112,100 Added 153.35%
185,200 $32.8 Million
Q1 2022

May 16, 2022

SELL
$119.61 - $157.85 $19.8 Million - $26.1 Million
-165,200 Reduced 69.32%
73,100 $10.5 Million
Q4 2021

Feb 14, 2022

BUY
$142.57 - $190.86 $1.53 Million - $2.04 Million
10,700 Added 4.7%
238,300 $36.8 Million
Q3 2021

Nov 15, 2021

BUY
$142.45 - $169.82 $16.4 Million - $19.5 Million
114,800 Added 101.77%
227,600 $38.6 Million
Q2 2021

Aug 11, 2021

SELL
$135.08 - $161.1 $5 Million - $5.96 Million
-37,000 Reduced 24.7%
112,800 $17.8 Million
Q1 2021

May 17, 2021

SELL
$137.51 - $190.8 $6 Million - $8.32 Million
-43,600 Reduced 22.54%
149,800 $20.8 Million
Q4 2020

Feb 16, 2021

BUY
$164.63 - $211.93 $31.8 Million - $41 Million
193,400 New
193,400 $33.9 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.